Preoperative Immune-Inflammatory Status of the Patients With Newly-Diagnosed Glioblastoma – Could It Genuinely Predict Their Survival?

Abstract

Our study does not provide enough evidence for the immune/inflammatory status of GBM patients to be used as an efficient prognostic marker to guide the therapeutic approach.